Dr. Sheng Lin-Gibson is the Chief of the NIST Biosystems and Biomaterials Division. She oversees a multidisciplinary research portfolio that includes regenerative medicine and advanced therapies, precision medicine, synthetic biology, and complex microbial systems. She leads and coordinates the development of global standards for emerging biotechnology and biomanufacturing. She has coauthored over 80 peer-reviewed publications, serves on many White House National Science andTechnology Council (NSTC)Interagency Working Groups, White House National Security Council (NSC)Interagency Working Group, as well as numerous expert review panels and advisory boards. She has received threeDepartment of Commerce Gold Medals.

Talks

• Panel Discussion
• Public-Private Partnerships to Address Common Cell and Gene Therapy Measurement Challenges